Sharma, B.K. et al. 2010. QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain. European Journal of Chemistry. 1, 4 (Dec. 2010), 325–334. DOI:https://doi.org/10.5155/eurjchem.1.4.325-334.195.